| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
2e-18 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
9e-18 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-12 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-10 |
| mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
1e-07 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
9e-07 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |